Get started
Author

Shunichiro Yasuda

Observed names: Yasuda Shun'ichiro, Yasuda, Shunichiro
ORCID: 0009-0004-3958-7870
Observed ORCID: 0009-0004-3958-7870
OpenAlex ID: A5001274498
Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy
2016 · Shunichiro Yasuda, Keisuke Tanaka, et al. · International Journal of Hematology · 23
Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation
2017 · Kaito Harada, Noritaka Sekiya, et al. · BMC Infectious Diseases · 21
PDF
Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study
2021 · Shunichiro Yasuda, Yuho Najima, et al. · Leukemia Research · 13
Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia
2019 · Tatsuya Konishi, Noriko Doki, et al. · Annals of Hematology · 11
Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab
2016 · Shunichiro Yasuda, Masahide Yamamoto, et al. · Internal Medicine · 9
PDF
Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens
2019 · Shunichiro Yasuda, Yuho Najima, et al. · Journal of Infection and Chemotherapy · 8
A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells
2022 · Satoru Aoyama, Shunichiro Yasuda, et al. · International Journal of Molecular Medicine · 6
PDF
Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation
2016 · Kaito Harada, Yuta Yamada, et al. · International Journal of Hematology · 6
MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations
2021 · Shunichiro Yasuda, Satoru Aoyama, et al. · International Journal of Hematology · 5
A Novel Protease-Mediated Chimeric Antigen Receptor (CAR): "Double-Arm" CAR-T Cell System Improves Target Specificity of CAR-T Cell Therapy
2019 · Satoru Aoyama, Shunichiro Yasuda, et al. · Blood · 2
[Disseminated fusariosis in patients with acute leukemia: a retrospective analysis of three cases].
2017 · Shuhei Kurosawa, Noritaka Sekiya, et al. · PubMed · 2
Refractory Hypoglycemia Secondary to the Warburg Effect in Diffuse Large B-Cell Lymphoma
2025 · Miho Shiomura, Takako Watanabe, et al. · JCEM Case Reports · 1
Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2 V617F mutation
2024 · Shunichiro Yasuda, Momoko Chiba, et al. · Clinical Case Reports · 1
PDF
Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation
2017 · Kazuhiko Ikeuchi, Noriko Doki, et al. · Internal Medicine · 1
PDF
[Inotuzumab ozogamicin-associated sinusoidal obstruction syndrome/veno-occlusive disease diagnosed by transjugular liver biopsy].
2025 · Shunichiro Yasuda, Momoko Chiba, et al. · PubMed
Abstract 3117: CD80 can be the marker of chronic myeloid leukemia stem cells and regulated by BCR-ABL signaling
2021 · Huixin Li, Shunichiro Yasuda, et al. · Cancer Research
MPL Overexpression Induces a High Level of Mutant-Calr/MPL Complex: A Novel Mechanism of Ruxolitinib Resistance in Myeloproliferative Neoplasms with Calr Mutations
2020 · Shunichiro Yasuda, Satoru Aoyama, et al. · Blood
A Protease-Mediated Regulatory Chimeric Antigen Receptor (CAR): "Double Arm" CAR System Improves Tumor-Cell-Specificity of CAR-T Cell Therapy
2020 · Satoru Aoyama, Shunichiro Yasuda, et al. · Blood
Abstract 2167: A protease-mediated regulatory chimeric antigen receptor (CAR): “Scissors” CAR improves target-specificity through regulation of T-cell activity
2020 · Satoru Aoyama, Shunichiro Yasuda, et al. · Cancer Research
Late appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ
2020 · Akihito Nagata, Noriko Doki, et al. · Leukemia & lymphoma/Leukemia and lymphoma
Overexpression of MPL Causes Ruxolitinib-Resistance in Myeloproliferative Neoplasms with Calreticulin Frame-Shift Mutations
2019 · Shunichiro Yasuda, Satoru Aoyama, et al. · Blood
MPL overexpresion is a mechanism of ruxolitinib resistance in CALR mutant MPN cells
2019 · Shunichiro Yasuda · The Japanese Society of Hematology
A Novel Cell Line, Tnet-2, Derived from "Triple-Negative" Essential Thrombocythemia
2018 · Satoru Aoyama, Toshikage Nagao, et al. · Blood
Introduction of CALR and JAK2 V617F mutations to UT-7/Epo and K562 by the CRISPR/Cas9 system
2018 · Shunichiro Yasuda · The Japanese Society of Hematology
Abstract 4338: Introduction of CALR mutations to a human erythroleukemia cell line, HEL, by CRISPR/Cas9 systems
2018 · Shunichiro Yasuda, Satoru Aoyama, et al. · Cancer Research
Works count: 30
Citation count: 109
H-index: 6
I10-index: 4
Year
Topic
Type